×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CADL – candel therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CADL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/29
09:07 am
cadl
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer [Yahoo! Finance]
Neutral
Report
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer [Yahoo! Finance]
4/29
08:05 am
cadl
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
Low
Report
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
4/21
10:41 am
cadl
Candel Therapeutics: 'Cancer Vaccine' Buy Thesis Appears Compelling [Seeking Alpha]
Medium
Report
Candel Therapeutics: 'Cancer Vaccine' Buy Thesis Appears Compelling [Seeking Alpha]
4/20
07:21 am
cadl
Candel Therapeutics (CADL) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.
High
Report
Candel Therapeutics (CADL) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.
4/9
06:24 am
cadl
Candel Therapeutics (CADL) was downgraded by Zacks Research from "hold" to "strong sell".
Medium
Report
Candel Therapeutics (CADL) was downgraded by Zacks Research from "hold" to "strong sell".
4/2
04:05 pm
cadl
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/17
09:58 am
cadl
Candel Therapeutics reports extended survival in Phase 2a lung cancer trial of CAN-2409 [Yahoo! Finance]
Low
Report
Candel Therapeutics reports extended survival in Phase 2a lung cancer trial of CAN-2409 [Yahoo! Finance]
3/17
08:29 am
cadl
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors [Yahoo! Finance]
Low
Report
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/12/2026
08:05 am
CADL
candel therapeutics, inc.
MISS
Report
-0.4%
candel therapeutics, inc.
11/13/2025
08:25 am
CADL
candel therapeutics, inc.
MISS
Report
-8.3%
candel therapeutics, inc.
8/14/2025
08:05 am
CADL
candel therapeutics, inc.
BEAT
Report
-5.0%
candel therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/29
04:13 pm
cadl
Form ARS Candel Therapeutics, For: Dec 31
Low
Report
Form ARS Candel Therapeutics, For: Dec 31
4/29
04:11 pm
cadl
Form DEFA14A Candel Therapeutics,
Low
Report
Form DEFA14A Candel Therapeutics,
4/29
04:06 pm
cadl
Form DEF 14A Candel Therapeutics, For: Jun 23
Low
Report
Form DEF 14A Candel Therapeutics, For: Jun 23
4/27
04:14 pm
cadl
Form SCHEDULE 13G/A Candel Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A Candel Therapeutics, Filed by: BlackRock, Inc.
4/2
05:17 pm
cadl
Form 4 Candel Therapeutics, For: Mar 31 Filed by: Manning Paul B
Low
Report
Form 4 Candel Therapeutics, For: Mar 31 Filed by: Manning Paul B
4/2
05:11 pm
cadl
Form 4 Candel Therapeutics, For: Mar 31 Filed by: PAPA JOSEPH C
Low
Report
Form 4 Candel Therapeutics, For: Mar 31 Filed by: PAPA JOSEPH C
4/2
05:08 pm
cadl
Form 4 Candel Therapeutics, For: Mar 31 Filed by: Loggia Nicoletta
Low
Report
Form 4 Candel Therapeutics, For: Mar 31 Filed by: Loggia Nicoletta
3/18
04:23 pm
cadl
Form SCHEDULE 13D/A Candel Therapeutics, Filed by: Manning Paul B
Low
Report
Form SCHEDULE 13D/A Candel Therapeutics, Filed by: Manning Paul B
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: